GenePath Diagnostics develops quantitative COVID-19 test kit for drug makers

The kit is currently being used by a couple of unidentified drug makers in India, said GenePath Diagnostics CEO Nickhil Jakatdar. He said this is the first quantitative test kit of its kind in India for Covid-19 and over time it could be used to test for other infectious diseases as well.
Source: The Economic Times - Category: Consumer Health News Source Type: news